NATCAPSUQ NSE filing

Voting Results and Scrutinizer’s Report of AGM held on 4 Aug 2025

The RealCase readMedium impact Positive

Why it matters

The passing of resolutions related to director appointments, auditor appointments, and related party transactions has a moderate impact on the company's operations and governance.

The market read

All resolutions were passed with unanimous support, indicating a positive outcome for the company's governance and strategic decisions.

* Natural Capsules Limited held its Annual General Meeting (AGM) on 4 August 2025. * The meeting was conducted through Video Conferencing (VC). * Deepak Sadhu was appointed as the Scrutinizer for the e-voting process. * The remote e-voting facility was available from 1 August 2025 to 3 August 2025. * The notice of the AGM was sent to members on 11 July 2025 and published in Business Line (English) and Sanjevani (Kannada) on the same date. * All eight resolutions proposed at the AGM were passed with 100% of the votes cast in favor. * The resolutions included: * Adoption of the audited consolidated and standalone financial statements for the year ended 31 March 2025. * Appointment of directors in place of retiring directors Shri Sathyanarayana Mundra and Shri Sushil Kumar Mundra. * Continuation of Shri. Tekkar Yashwanth Prabhu as Non-Executive Independent Director beyond the age of 75 years. * Reappointment of Shri Sathyanarayana Mundra as Whole Time Director and revision of remuneration. * Appointment of Mr. R Parthasarthy as Secretarial Auditors for 5 years. * Approval of related party transactions with subsidiary, Natural Biogenex Private Limited. * Payment of Commission to Non-Executive Directors.

Filing to action

What to do with a filing like this

Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.

View original filing